+44 (0)115 787 0175 enquiry@upperton.com

cGMP Manufacturing

Seamless transition from feasibility batches to clinical trials material

Upperton offers a seamless transition from initial feasibility and development studies right through to cGMP spray drying and production of the final dosage form for human clinical trials.

Our cGMP spray drying is undertaken at the Quotient Sciences MHRA-approved facility in Nottingham.

Our cGMP capabilities include:

  • Spray drying (aqueous and solvent)
  • Scale up of production from grams to kilograms of formulated API
  • Further processing through to final dosage form (e.g. capsule filling, tableting, device filling)
  • Intermediate and finished product testing
  • QA release (by in-house Qualified Person)
  • Stability testing to ICH guidelines

The spray dried intermediate or final dosage form can be delivered to the designated clinical trials site or alternatively the trial formulation can be administered to volunteers in the Quotient clinical trials facility.

About Us

With over 20 years of experience we have successfully spray dried, formulated and characterised a vast range of pharmaceutical and biotechnology products for companies across the globe.

MORE DETAILS

Contact Us

Would you like to find out more about our services or how we can help advance your project?

MORE DETAILS

Latest News

- Address

Upperton Ltd
BioCity Nottingham
Pennyfoot Street
Nottingham
NG1 1GF

- Contact
+44 (0)115 787 0175
enquiry@upperton.com